Novotech 的亚太地区和美国领导团队参加 BIO 2022
SAN DIEGO, CA, Jun 15, 2022 – (亚太商讯 via SEAPRWire.com) – Novotech 是亚太地区领先的生物技术临床研究机构，最近将其服务扩展到美国，将邀请来自亚太地区和美...
Novotech助力Endpoints ASCO 2022年专家组，加速中国肿瘤临床试验
SYDNEY, Jun 7, 2022 – (亚太商讯 via SEAPRWire.com) – Novotech是亚太地区领先的生物技术临床研究机构，近期入驻美国，助力Endpoints ASCO 2022年专家组...
Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China
SYDNEY, Jun 6, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, is sponsoring the […]
Novotech 赞助 ASCO 中国峰会前中美早期肿瘤试验和监管策略专家组
SYDNEY, Jun 3, 2022 – (亚太商讯 via SEAPRWire.com) – Novotech 是亚太地区领先的生物技术专家 CRO，最近将其服务扩展到美国，在 2022 年 ASCO 前中国峰会...
Novotech 赞助 ASCO 中国峰会前夕：基于早期肿瘤学试验的 Go/No Go 决策
SYDNEY, May 12, 2022 – (亚太商讯 via SEAPRWire.com) – Novotech 是亚太地区领先的生物技术专家 CRO，最近将其 CRO 服务扩展到美国，很高兴赞助 2022 年 ...
Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials
SYDNEY, May 12, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its CRO services to the US, is pleased […]
Novotech Acquires US CRO NCGS, Expands Global Expertise
Singapore & Charlotte, NC, May 5, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia-Pacific biotech specialist CRO, has acquired US CRO NCGS as part of its expansion […]